is gila monster venom used in glp 1 inspires Ozempic and new species treatment The strange link between a

Healthcare professionals must therefore balance the substantial benefits of GLP-1 therapy against this potential, though uncommon, risk when prescribing these agents

GLP-1, the Gut-Brain Axis, and Pain Modulation

Why Weight Loss May Plateau on GLP-1 Treatment Patients frequently experience substantial weight loss during the initial months of GLP-1 therapy, but many notice a plateau effect where weight reduction slows or stabilises after 612 months of treatment

This is not a marginal difference

From the perspective of the gut microbiota, this review explains that nutrients can enhance the abundance and diversity of the gut microbiota, reduce inflammation, and ultimately improve depression by regulating the gut-brain axis, promoting the synthesis of SCFAs, and modulating neurotransmitter production

Carriers are not affected by the disorder